Trial Profile
Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Telaprevir (Primary) ; Peginterferon alfa
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 11 Dec 2015 New trial record